Department of Hematology, Affiliated Hospital of Jining Medical University , Jining , Shandong , China.
Department of Digestive Medicine, Affiliated Hospital of Jining Medical University , Jining , Shandong , China.
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3671-3676. doi: 10.1080/21691401.2019.1596930.
Accumulating studies showed that microRNAs are maintaining a variety of important biological processes but the underlying mechanism in proliferation and tumourigenicity is unclear. In this study we show that miR-342 expression in bone marrow and patients' sera of childhood acute myeloid leukemia (AML) was both significantly higher than those in the corresponding normal controls. Functional assays demonstrated that forced expression of miR-342 significantly suppresses AML cell proliferation and G1/S transition of leukemia cells. Mechanistically, bioinformatics prediction and luciferase reporter assay identified N-a-acetyltransferase 10 protein (Naa10p) as a direct molecular target of miR-342, Naa10p siRNA significantly repressed cell proliferation and increased cell apoptosis. In conclusion, our study confirmed that miR-342/Naa10p plays key roles in AML progression, providing insights into underlying mechanisms of AML pathogenesis and also a potential therapeutic target for this malignancy.
越来越多的研究表明,microRNAs 参与维持多种重要的生物学过程,但在增殖和致瘤性中的潜在机制尚不清楚。在这项研究中,我们发现骨髓和急性髓细胞白血病(AML)患者血清中的 miR-342 表达均明显高于相应的正常对照。功能分析表明,miR-342 的强制表达显著抑制 AML 细胞的增殖和白血病细胞的 G1/S 期转变。从机制上讲,生物信息学预测和荧光素酶报告基因实验鉴定 N-a-乙酰转移酶 10 蛋白(Naa10p)是 miR-342 的直接分子靶点,Naa10p 的 siRNA 显著抑制细胞增殖并增加细胞凋亡。总之,我们的研究证实了 miR-342/Naa10p 在 AML 进展中发挥关键作用,为 AML 发病机制的潜在机制提供了新的见解,也为这种恶性肿瘤提供了一个潜在的治疗靶点。